Literature DB >> 15359250

Tadalafil-associated anterior ischaemic optic neuropathy.

N M Peter, M V Singh, P D Fox.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15359250     DOI: 10.1038/sj.eye.6701614

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  7 in total

1.  Can erectile dysfunction drug use lead to ischaemic optic neuropathy?

Authors:  H D Pomeranz
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

Review 2.  Vision disorders and phosphodiesterase type 5 inhibitors: a review of the evidence to date.

Authors:  Alan M Laties
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 3.  Erectile dysfunction drugs and risk of anterior ischaemic optic neuropathy: casual or causal association?

Authors:  Helen V Danesh-Meyer; Leonard A Levin
Journal:  Br J Ophthalmol       Date:  2007-11       Impact factor: 4.638

Review 4.  Phosphodiesterase type 5 inhibitors, visual changes, and nonarteritic anterior ischemic optic neuropathy: is there a link?

Authors:  Konstantinos Hatzimouratidis
Journal:  Curr Urol Rep       Date:  2007-11       Impact factor: 3.092

Review 5.  Phosphodiesterase Type 5 Inhibitors and Visual Side Effects: A Narrative Review.

Authors:  Francisco Barroso; João Crispim Ribeiro; Eduardo P Miranda
Journal:  J Ophthalmic Vis Res       Date:  2021-04-29

6.  Anterior Ischemic Optic Neuropathy in a Patient with Erectile Dysfunction: Tadalafil as an Offending Medication.

Authors:  Alireza Dehghani; Mohammad-Hasan Alemzadeh-Ansari; Marjan Masjedi; Arman Amirkhani; Mohsen Pourazizi
Journal:  J Res Pharm Pract       Date:  2018 Jul-Sep

7.  The phosphodiesterase 5 inhibitor tadalafil has renoprotective effects in a rat model of chronic kidney disease.

Authors:  Natsumi Tomita; Yuji Hotta; Aya Naiki-Ito; Kana Hirano; Tomoya Kataoka; Yasuhiro Maeda; Satoru Takahashi; Kazunori Kimura
Journal:  Physiol Rep       Date:  2020-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.